Literature DB >> 24002958

Significance of the disulphide bonds of human growth hormone.

Riia K Junnila1, John J Kopchick.   

Abstract

Growth hormone (GH) structure is stabilised by two disulphide bonds, C53-C165 and C182-C189 in human GH. Researchers have investigatedthe role of these structural features since the late 1960s. Early studies implied that the disulphide bonds would not be importantfor biological activity of GH. However, more advanced techniques, as well as clues from patients carrying mutations in their GH1 gene,have demonstrated that the integrity of the disulphide bond between cysteines C53 and C165 is required for biological activity of GH.In contrast, disruption of the C-terminal disulphide bond (C182-C189) has only modest effects on the biological potency of GH, despitedecreased binding affinity to GH receptor and reduced stability as shown by a comprehensive in vitro study.To confirm these results, we generated transgenic mice that express a human GH analogue, C189A, and observed normal growth-promotingand lipolytic activities. In this article, we present new data and review old results concerning the disulphide bonds of GH. We also discussrelevant mutations found in patients with growth disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24002958     DOI: 10.5603/ep.2013.0009

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  2 in total

1.  Prokaryotic soluble overexpression and purification of bioactive human growth hormone by fusion to thioredoxin, maltose binding protein, and protein disulfide isomerase.

Authors:  Minh Tan Nguyen; Bon-Kyung Koo; Thu Trang Thi Vu; Jung-A Song; Seon-Ha Chong; Boram Jeong; Han-Bong Ryu; Sang-Hyun Moh; Han Choe
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 2.  Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise.

Authors:  William J Kraemer; Nicholas A Ratamess; Wesley C Hymer; Bradley C Nindl; Maren S Fragala
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-25       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.